Stay up to date with news and events
SOM3355 Moves Toward Phase 3 as Both EMA and FDA Signal Support
November 21, 2025
SOM3355 is an investigational therapy aimed at managing multiple symptoms of Huntington’s disease (HD) and recently crossed two key regulatory milestones. In September, the European…
A Tiny Genetic Tweak Could Delay Symptoms and Activate Cellular Cleanup for Huntington’s Disease
November 18, 2025
Scientists often use genetics, the study of DNA, to understand the cellular changes that cause disease. By comparing people’s DNA with their symptoms, they can…
Unzipping the Secrets of DNA Repair
November 14, 2025
Our bodies are experts at looking after our DNA and are continuously monitoring for any damage that needs to be repaired to keep us healthy….
Tooth fairy therapy? Stem cells from teeth tested in a small Huntington’s disease trial
November 11, 2025
A small study from Brazil tested whether stem cells from human dental pulp, the soft tissue inside teeth, could help people with Huntington’s disease (HD)….
New insights into intermediate CAG repeats: Mapping the expansion continuum
November 6, 2025
Why do some people with intermediate CAG repeats, a genetic “gray zone” in Huntington’s disease, develop neurological symptoms while others do not? This article covers…